Novel Molecular Imaging Technologies

Hello! My name is Katie Parkins and I am a PhD candidate in the Department of Medical Biophysics at Western University. I work in the Imaging Research Laboratories at Robarts Research Institute under the co-supervision of Drs. Paula Foster and John Ronald.

Katie Parkins, PhD CandidateMy research involves using novel molecular imaging technologies to study concomitant tumour resistance (CTR): the ability of the primary tumour to inhibit the growth of secondary metastases. Tumor cell dormancy and recurrence are important clinical problems for breast cancer patients and their physicians as secondary metastases can develop many years after successful removal of the primary tumour and adjuvant therapy. We expect this research will produce important information about what influences metastatic tumour growth and possibly advance therapeutic development for breast cancer patients.

I have been fortunate to have many opportunities presenting my work at both international and regional conferences. My first author manuscript was published in the Nature Publishing Group journal, Scientific Reports, and recently recognized at the 2017 London Health Research Day as a recipient of the Lucille and Norton Wolf Publication Award. It’s very encouraging to see the interest in my work and the excitement for new results to come!

Thank you to BCSC for your trainee support!

– Katie Parkins, PhD Candidate

Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Health Sciences Centre

Close Menu